Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $2,680
3%  
Woo hoo!! 3rd Qtr 2025 FReepathon is now underway!!

Keyword: remdesiver

Brevity: Headers | « Text »
  • URGENT: Maryland National Guard to Distribute Remdesivir to Nursing Home Residents

    01/15/2022 9:29:35 AM PST · by Jan_Sobieski · 37 replies
    We Love Trump ^ | 01/13/2022 | Daniel_G
    I’ve noted the warnings about remdesivir as explained by Dr. Bryan Ardis, which is why I’ve labeled this the “Pandemic of Medical Malpractice.”As previously reported:Remdesivir BackgroundTo understand the severity of this scandal, let’s briefly review some background of how Remdesivir came into use for COVID-19.Remdesivir is a nucleotide analogue prodrug originally developed for the treatment of Ebola Virus.A New England Journal of Medicine study claimed that a single United States COVID-19 patient showed improvement after taking Remdesivir.Coincidentally, the Wuhan Institute of Virology sought a patent for the use of Remdesivir.But at the height of COVID-19, the NIH picked Remdesivir as...
  • Praise the Lord and pass the ivermectin

    01/05/2022 5:15:39 PM PST · by Jan_Sobieski · 16 replies
    WND ^ | 01/05/2022 | Joel S. Hirschhorn
    With over 1,200 daily COVID deaths for many weeks, the U.S. is on track to reach a total of 1 million COVID-related deaths by the end of March. A shameful record for 2022.To think that every week over 8,000 Americans are dying, mostly in hospital ICUs, is unbelievable – but that is no excuse for the lack of serious attention by the mainstream media. Take a moment to reflect that this is more deaths than those in the 9/11 attacks and Pearl Harbor, combined. And it is happening every week.Hospitals have become killing machines, places where the kiss of death...
  • UC researcher urges caution using remdesivir to treat COVID-19

    12/31/2020 12:56:46 PM PST · by aimhigh · 12 replies
    Eurekalert ^ | 12/31/2020 | UNIVERSITY OF CINCINNATI
    While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.Research at the University of Cincinnati, however, contends that this antiviral drug is being used too indiscriminately when treating patients hospitalized with the virus. The study is published in the journal Fundamental & Clinical Pharmacology. . . . In the UC study, lead author Bingfang Yan, a pharmaceutical scientist, and...